More on PLRZ
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.23 |
|
|||
| Open | $11.19 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $11.36 | ||||
| Day Low | $10.50 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 76,585 | ||||
- Form D Polyrizon Ltd.
- Polyrizon launches $4M registered direct offering and private placement
- Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
- Polyrizon signs all five U.S. sites for NASARIX allergy trial
- Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
- Form 6-K Polyrizon Ltd. For: Aug 20
- Polyrizon completes site contracts for Nasarix allergy trial
- Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
- Form SCHEDULE 13G/A Polyrizon Ltd. Filed by: MMCAP International Inc. SPC
- Form 6-K Polyrizon Ltd. For: Jul 13
Entities mentioned with PLRZ
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- F1 | View Related Stories »
- 13G | View Related Stories »
- IPO | View Related Stories »
- Show More...
